On July 7, Kelun-Biotech (06990.HK) declined 3.06% in regular trading, trading at HK$506.0 per share, with turnover of HK$561 million.
Within the Biotechnology sector where Kelun-Biotech belongs, the overall sector showed broad weakness. Among individual stocks, Innovent Bio down 4.48%, Akeso down 4.86%, 3SBio down 7.56%, BeiGene down 3.78%, Keymed Bio-B down 3.86%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)